Developing new inhaled therapies for tuberculosis treatment
Inhalational therapy with spectinamides within new regimens of TB therapy
This study is looking for better ways to treat tuberculosis (TB) by testing new combinations of medicines that are easier to take and work faster, so patients can feel better with fewer side effects.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Colorado State University NIH-funded |
| Lab location | 1 site (Fort Collins, United States) |
| Project ID | NIH-10918543 on NIH RePORTER |
What this research studies
This research aims to create shorter and safer therapies for tuberculosis (TB) that require fewer pills and have a reduced duration of treatment. The approach involves testing new drug combinations in preclinical models before moving to clinical trials. One promising strategy is to replace a commonly used drug with spectinamides, which can be administered via aerosol and have shown effectiveness against various strains of TB. The goal is to improve patient outcomes by minimizing adverse effects while maintaining efficacy.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with drug-sensitive or multidrug-resistant tuberculosis.
Not a fit: Patients with non-tuberculosis related respiratory conditions or those who are not infected with TB may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and tolerable treatments for tuberculosis, reducing the burden on patients.
How similar studies have performed: Previous research has successfully developed effective TB regimens using similar approaches, indicating potential for success in this novel treatment strategy.
Where this research is happening
Fort Collins, United States
- Colorado State University — Fort Collins, United States (Active)
Researchers
- Principal investigator: Gonzalez-Juarrero, Mercedes — Colorado State University
- Study coordinator: Gonzalez-Juarrero, Mercedes
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.